DAYBUE Rett Syndrome Data from LOTUS Study Published in Journal
September 15, 2025
Findings reinforce efficacy and tolerability profile in patients prescribed DAYBUE in the U.S. for as long as 12 months, consistent with the Phase 3 LAVENDER